Table 3 PPP-adjusted prices of the selected cancer originator drugs in the 10 surveyed countries converted to USD
Low middle income | High middle income | High income | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Generic name | Presentation | PAK($) | EGY($) | MYS($) | LBN($) | THA($) | TWN ($) | OMN ($) | BHR ($) | ARE($) | SAU($) | Mean unit price for drugs | High/Low ratio |
Abiraterone acetate 250 mg | 120 tab | NA | 9724·22 | NA | NA | NA | NA | NA | NA | 8470·08 | 8867·61 | 70·17 | 1·73 |
1 tab | NA | 81·04 | NA | NA | 52·02 | 59·10 | 90·21 | 64·33 | 70·58 | 73·90 | |||
Bevacizumab 25 mg/ml | Inj. 100 mg (4 ml) | NA | 1233·18 | NA | NA | 1473·00 | 602·10 | 4122·80 | 767·00 | 1157·95 | NA | 1559·50 | 6·85 |
Bortemozib3.5 mg | 1 vial | NA | NA | 3622·22 | 2243·96 | 4630·12 | 2443·02 | 3878·90 | 2771·38 | 2560·04 | NA | 3164·22 | 2·06 |
Cabazitaxel 60 mg | 1 vial | NA | NA | 11,492·5 | 7112·50 | NA | NA | 17,304·95 | NA | 11,421·76 | NA | 11,832·93 | 2·43 |
Cetuximab 5 mg/ml | 1 vial | NA | NA | 1100·49 | 1850·55 | 997·12 | 456·25 | NA | NA | NA | NA | 1101·10 | 4·06 |
Denosumab 60 mg/ml | 1 ml prefilled syringe | NA | 798·21 | NA | 607·36 | 934·69 | 417·41 | 757·00 | NA | 665·27 | NA | 696·66 | 2·24 |
ErlotinibHCl 150 mg | 30 film coated tab | 7315.34 | 11,659·19 | NA | NA | NA | NA | NA | NA | 6837·45 | NA | 194·84 | 4·93 |
1 film coated tab | 243.84 | 388·64 | NA | NA | 160.54 | 78.76 | 152.5789 | 111.62 | 227.915 | NA | |||
Everolimus 10 mg | 30 tab | NA | 8565·02 | NA | NA | NA | NA | NA | NA | 8514·64 | 8697·73 | 300·53 | 1·83 |
1 tab | NA | 285·50 | NA | 274·21 | 404·60 | 220·25 | 338·68 | 307·24 | 283·82 | 289·92 | |||
Gefitinib 250 mg | 30 film-coated tablets | NA | NA | NA | NA | NA | NA | NA | NA | 3938.70 | NA | 144·33 | 2·40 |
1 film-coated tab | NA | NA | 173·85 | 123·84 | 157·52 | 82·79 | 198·89 | 142·14 | 131·29 | NA | |||
Gemcitabine 1 g | Vial | 295·81 | 210·77 | 496·53 | 227·33 | 179·04 | 271·28 | 359·10 | 256·57 | 281·60 | NA | 286·45 | 2·77 |
ImatinibMesylate 100 mg | 60 film-coated tab | 2485·80 | 5156·95 | NA | NA | NA | NA | NA | NA | 2920·71 | 3571·02 | 56·92 | 3·41 |
1 film-coated tab | 41·43 | 85·95 | 63.49 | 25·23 | 74·14 | 41·43 | 72·47 | NA | 48·68 | 59·50 | |||
Interferon Alpha - 2B 1 m IU/injection | 1 multidose pen | 208·81 | NA | NA | 21·02 | NA | 26·80 | NA | 72·71 | 65·69 | 287·50 | 113·76 | 13·68 |
Lapatinibditosylate 250 mg | 70 film-coated tablets | 3341.73 | 1926·91 | NA | NA | NA | NA | NA | NA | 2526·36 | 4190·34 | 40·08 | 2·68 |
1 film coated tab | 47.74 | 27·53 | NA | 32·39 | 22·30 | NA | 54·68 | NA | 36·09 | 59·86 | |||
Nilotinib 150 mg | 112 caps | NA | 2152·47 | NA | NA | NA | NA | NA | NA | 7906·28 | 9474·43 | 66·07 | 5·56 |
1 cap | NA | 19·22 | NA | 59·16 | 70·76 | 43·68 | 106·95 | 73·62 | 70·59 | 84·59 | |||
Nilotinib 200 mg | 112 caps | 15,113·64 | 2982·06 | NA | NA | NA | NA | NA | NA | 11,069·25 | 12,631·82 | 92·78 | 5·07 |
1 cap | 134·94 | 26·62 | 116·07 | NA | NA | 67·44 | NA | NA | 98·83 | 112·78 | |||
Paclitaxel Albumin 5 mg/ml | 1 vial | 213·07 | NA | 125 | 624·90 | 242·70 | 91·86 | 348·21 | NA | NA | NA | 274·29 | 6·80 |
Panitumumab 20 mg/ml | 1 vial | NA | 4932·74 | NA | NA | NA | NA | 7223·84 | 1291·00 | 5804·39 | 1482·96 | 4147·00 | 5·60 |
Pazopanib 200 mg | 30 tab | NA | 762·33 | NA | NA | NA | NA | NA | NA | 1604.18 | 1994·89 | 52·20 | 3·19 |
1 tab | NA | 25·411 | NA | 36.92 | 51·59 | 44·80 | 81 | 57·90 | 53·47 | 66·496 | |||
Pemetrexed Disodium Heptahydrate 500 mg | 1 vial | 2485·80 | 3295·96 | 694·44 | 624·77 | 795·70 | 502·78 | NA | 2879·24 | 3200·21 | 3307·96 | 1976·32 | 6·58 |
Sorafenib 200 mg | 6 × 10’s tablets | 8267·05 | 5025·56 | NA | NA | Na | NA | NA | NA | 4920·29 | 6620·46 | 97·23 | 1·91 |
1 tab | 137·78 | 83·76 | NA | NA | NA | 72·27 | NA | NA | 82·00 | 110·34 | |||
Sunitinib malate 12.5 mg | 30 caps | 3597·66 | 2578·48 | NA | NA | NA | NA | NA | NA | 3323·22 | 3425·57 | 108·22 | 1·75 |
1 cap | 119·92 | 85·95 | 150·47 | NA | 89·2 | 87·03 | NA | NA | 110·77 | 114·19 | |||
Sunitinib malate 25 mg | 30 caps | 7121·80 | 7134·08 | NA | NA | NA | NA | NA | NA | 6646·44 | 6851·71 | 231·28 | 1·07 |
1 cap | 237·39 | 237·80 | NA | NA | NA | NA | NA | NA | 221·55 | 228·39 | |||
Sunitinib malate 50 mg | 30 caps | 13,943·18 | 10,762·33 | NA | NA | NA | NA | NA | NA | 13,292·89 | 13,703·98 | 405·56 | 1·49 |
1 cap | 464·77 | 358·74 | NA | NA | NA | 312·31 | NA | 397·62 | 443·096 | 456·80 | |||
Trastuzumab 440 mg | 1 vial | 4616·48 | 4686·10 | NA | NA | NA | 3930·91 | NA | NA | NA | NA | 4779·35 | 1·50 |
Transtuzumab 150 | 1 vial | NA | NA | NA | NA | 1240·85 | NA | 2599·53 | 1857·33 | 5883·89 | 2133·52 | 1957·81 | 2·09 |
Zolendronic acid 4 mg/5 ml | 1 vial | 674·72 | 605·38 | NA | NA | 268·79 | NA | NA | NA | NA | 845·45 | 598·59 | 3·15 |
Mean unit price for every country | 708·75 | 919·39 | 1803·51 | 990·30 | 658·09 | 492·61 | 2355·60 | 789·26 | 1496·34 | 607·13 | |||
Average unit price by world bank categories | 814.07 | 1150.63 | 1148.19 | ||||||||||